| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Pamicogrel |
101001-34-7 |
101001-34-7 |
详细
|
| Canertinib |
卡奈替尼 |
267243-28-7 |
详细
|
| AV-412 |
AV 412 |
451493-31-5 |
详细
|
| Erlotinib D6 hydrochloride |
埃罗替尼-D6 盐酸盐 |
1189953-78-3 |
详细
|
| Pyrotinib dimaleate |
马来酸吡咯替尼 |
1397922-61-0 |
详细
|
| inS3-54A18 |
328998-53-4 |
328998-53-4 |
详细
|
| Citronellol |
香茅醇 |
106-22-9 |
详细
|
| RSVA405 |
化合物RSVA 405 |
140405-36-3 |
详细
|
| JAK3-IN-6 |
JAK3-IN-6 |
1443235-95-7 |
详细
|
| Cridanimod |
吖啶酮乙酸 |
38609-97-1 |
详细
|
| RTC-5 |
RTC-5 |
1423077-49-9 |
详细
|
| Sodium dichloroacetate |
二氯乙酸钠 |
2156-56-1 |
详细
|
| 3-Indolepropionic acid |
吲哚-3-丙酸 |
830-96-6 |
详细
|
| DL-Norvaline |
DL-正缬氨酸 |
760-78-1 |
详细
|
| Almonertinib |
阿美替尼 |
1899921-05-1 |
详细
|
| STAT3-IN-1 |
STAT3-IN-1 |
2059952-75-7 |
详细
|
| Epertinib hydrochloride |
EPERTINIB HYDROCHLORIDE |
2071195-74-7 |
详细
|
| UC-514321 |
化合物UC-514321 |
299420-83-0 |
详细
|
| Tyrphostin AG30 |
酪氨酸磷酸化抑制剂 AG 30 |
122520-79-0 |
详细
|
| Protosappanin A |
原苏木素A |
102036-28-2 |
详细
|
| RO8191 |
8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE |
691868-88-9 |
详细
|
| Nitroflurbiprofen |
158836-71-6 |
158836-71-6 |
详细
|
| (R)-Lisofylline |
1-(5-hydroxyhexyl)-3,7-dimethyl-purine-2,6-dione |
100324-81-0 |
详细
|
| Theliatinib |
席栗替尼 |
1353644-70-8 |
详细
|
| PF-06651600 |
利特昔替尼 |
1792180-81-4 |
详细
|
| INCB053914 phosphate |
CS-2873 |
2088852-47-3 |
详细
|
| SC57666 |
158959-32-1 |
158959-32-1 |
详细
|
| JND3229 |
JND3229 |
2260886-64-2 |
详细
|
| Dupilumab |
度匹鲁单抗 |
1190264-60-8 |
详细
|
| CGP52411 |
CGP 52411 |
145915-58-8 |
详细
|
| Ethyl Caffeate |
咖啡酸乙酯 |
102-37-4 |
详细
|
| Norgestrel |
炔诺孕酮 |
6533-00-2 |
详细
|
| Benzyl butyl phthalate |
邻苯二甲酸丁苄酯 |
85-68-7 |
详细
|
| Human PD-L1 inhibitor IV |
HUMAN PD-1 PROTEIN抑制剂多肽 |
2135542-83-3 |
详细
|
| Kaempferol 3-O-β-D-glucuronide |
山奈酚葡萄糖醛酸苷 |
22688-78-4 |
详细
|
| Pim1/AKK1-IN-1 |
N-[5-(4-氰基苯基)-1H-吡咯并[2,3-B]吡啶-3-基]-3-吡啶甲酰胺 |
1093222-27-5 |
详细
|
| STAT5-IN-1 |
STAT5 Inhibitor |
285986-31-4 |
详细
|
| FR-188582 |
189699-82-9 |
189699-82-9 |
详细
|
| AZD4205 |
AZD4205 |
2091134-68-6 |
详细
|
| PF-06263276 |
PF-06263276 (PF 6263276) |
1421502-62-6 |
详细
|
| Gefitinib-based PROTAC 3 |
Gefitinib-based PROTAC 3 |
2230821-27-7 |
详细
|
| Reslizumab |
RESLIZUMAB |
241473-69-8 |
详细
|
| Tyk2-IN-5 |
TYK2-IN-5 |
1797432-62-2 |
详细
|
| G5-7 |
化合物JAK2 INHIBITOR G5-7 |
939681-36-4 |
详细
|
| Tat-NR2Baa |
Tat-NR2Baa |
847829-41-8 |
详细
|
| PKI-166 |
PKI 166 |
187724-61-4 |
详细
|
| BMS-690514 |
(3R,4R)-4-氨基-1-[[4-[(3-甲氧基苯基)氨基]吡咯并[2,1-F][1,2,4]三嗪-5-基]甲基]哌啶-3-醇 |
859853-30-8 |
详细
|
| HO-3867 |
HO-3867 |
1172133-28-6 |
详细
|
| Nivolumab |
纳武单抗 |
946414-94-4 |
详细
|
| Phenidone |
菲尼酮 |
92-43-3 |
详细
|
| Neoseptin 3 |
1622863-21-1 |
1622863-21-1 |
详细
|
| G3-C12 |
G3-C12 |
848301-94-0 |
详细
|
| Pyrotinib Racemate |
1246089-97-3 |
1246089-97-3 |
详细
|
| Almonertinib hydrochloride |
HS-10296 HYDROCHLORIDE |
2134096-03-8 |
详细
|
| SC99 |
SC-99 |
882290-02-0 |
详细
|
| Pam3CSK4 TFA |
化合物PAM3CSK4 TFA |
112208-01-2 |
详细
|
| Pelargonidin chloride |
氯化花葵素 |
134-04-3 |
详细
|
| Bropirimine |
溴匹立明 |
56741-95-8 |
详细
|
| AV-412 free base |
AV-412 |
451492-95-8 |
详细
|
| Fedratinib hydrochloride hydrate |
TG-101348 |
1374744-69-0 |
详细
|
| AF12198 |
AC-PHE-GLU-TRP-THR-PRO-GLY-TRP-TYR-GLN-L-AZETIDINE-2-CARBONYL-TYR-ALA-LEU-PRO-LEU-NH2 |
185413-30-3 |
详细
|
| HJC0152 hydrochloride |
2-(2-氨基乙氧基)-5-氯-N-(2-氯-4-硝基苯基)苯甲酰胺盐酸盐 |
1420290-99-8 |
详细
|
| Tat-NR2B9c TFA |
TAT-NR2B9C TFA |
1834571-04-8 |
详细
|
| Benralizumab |
BENRALIZUMAB |
1044511-01-4 |
详细
|
| SHR0302 |
化合物SHR0302 |
1445987-21-2 |
详细
|
| Ustekinumab |
乌司奴单抗 |
815610-63-0 |
详细
|
| Phenethyl ferulate |
阿魏酸苯乙酯 |
71835-85-3 |
详细
|
| PD-161570 |
PD-161570;PF-1480232 |
192705-80-9 |
详细
|
| ARRY-380 (analog ) |
ARRY-380 |
937265-83-3 |
详细
|
| Momelotinib sulfate |
N-(氰基甲基)-4-[2-[[4-(4-吗啉基)苯基]氨基]-4-嘧啶基]苯甲酰胺硫酸盐(1:2) |
1056636-06-6 |
详细
|
| PD-089828 |
PD089828 |
179343-17-0 |
详细
|
| HKI-357 |
HKI 357 |
848133-17-5 |
详细
|
| SMI-16a |
PIM1/2 KINASE INHIBITOR VI |
587852-28-6 |
详细
|
| TyK2-IN-2 |
2098466-94-3 |
2098466-94-3 |
详细
|
| FM-381 |
(E)-2-CYANO-3-(5-(1-CYCLOHEXYL-1,6-DIHYDROIMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-2-YL)FURAN-2-YL)-N,N-DIMETHYLACRYLAMIDE |
2226521-65-7 |
详细
|
| D-Kynurenine |
犬尿氨酸 |
13441-51-5 |
详细
|
| TAS6417 |
1661854-97-2 |
1661854-97-2 |
详细
|
| JAK/HDAC-IN-1 |
JAK/HDAC-IN-1 |
2284621-75-4 |
详细
|
| Hydroxychloroquine |
羟基氯喹 |
118-42-3 |
详细
|
| NLRP3-IN-2 |
4-[2-(5-氯-2-甲氧基苯甲酰氨基)乙基]苯磺酰胺 |
16673-34-0 |
详细
|
| SH5-07 |
1456632-41-9 |
1456632-41-9 |
详细
|
| MTX-211 |
MTX-211 |
1952236-05-3 |
详细
|
| STAT5-IN-2 |
STAT5-IN-2 |
2111834-61-6 |
详细
|
| AMY-101 TFA |
AMY-101 TFA |
1789738-04-0 |
详细
|
| Compstatin |
COMPSTATIN |
206645-99-0 |
详细
|
| 7,3',4'-Tri-O-methylluteolin |
5-羟基-7,3',4'-三甲氧基黄酮 |
29080-58-8 |
详细
|
| 2,5-Di-tert-butylhydroquinone |
2,5-二特丁基对苯二酚 |
88-58-4 |
详细
|
| Durvalumab |
德瓦鲁单抗 |
1428935-60-7 |
详细
|
| Atezolizumab |
阿特珠单抗 |
1380723-44-3 |
详细
|
| Methyl Salicylate |
水杨酸甲酯 |
119-36-8 |
详细
|
| EGFR-IN-5 |
EGFR-IN-5 |
2225887-26-1 |
详细
|
| BMS-599626 Hydrochloride |
BMS-599626 |
873837-23-1 |
详细
|
| TP-3654 |
TP3654 |
1361951-15-6 |
详细
|
| BP-1-102 |
4-(N-(4-环己基苄基)-2-((2,3,4,5,6-五氟-N-甲苯基)磺酰氨基)乙酰氨基)-2-羟基苯甲酸 |
1334493-07-0 |
详细
|
| TX1-85-1 |
TX1-85-1 |
1603845-32-4 |
详细
|
| CCT365623 hydrochloride |
CCT365623 |
2126136-98-7 |
详细
|
| RG13022 |
RG-13022 |
136831-48-6 |
详细
|
| PF-06700841 P-Tosylate |
CS-2860 |
2140301-96-6 |
详细
|
| Di-O-methyldemethoxycurcumin |
Di-O-methyldemethoxycurcumin |
824951-60-2 |
详细
|
| Human PD-L1 inhibitor II |
|
2135542-85-5 |
详细
|